Doosan Group’s Yonkang Foundation (Chairman Y.H. Park) donated 100 million won(US$ 75,000) to Seoul National University (SNU) Hospital to support its cancer research on March 31.

The research grant will be used for conducting three research projects, including “development of blood-based diagnostic method for solid organic cancer using DNA methylation marker” led by Prof. Kyung-hun Kang at the department of surgery at the hospital.

Chairman Park said, “As the number of patients who suffer from cancer continues to increase, the promotion of cancer research has become an urgent task,” adding, “Doosan Group’s Yongkang Foundation will take the lead in the efforts for treatment and prevention of

cancer by providing research grants on the long-term basis, rather than short-term support.”

Yonkang Foundation began the project to support cancer research at SNU Hospital in 2006. The foundation selects three projects among basic research plans, which can be applied to treatment and clinical medicine, and donates 100 million won(US$ 75,000)  per year

to grant an aggregate total of 1 billion won(US$ 7.5 million)  through 2015.

Doosan Group’s Yonkang Foundation, dedicated to scholarship programs and academic assistance, has been providing scholarships, academic and cultural promotion programs since its inception in 1978.